Figure 3From: Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencingAn example for evaluating the risk of obesity by using bacterial disease risk evaluation model. The model used lower and upper proportion bound of 9 markers from 98 control samples to define risk markers of these two samples (B034 and B031) following by using binomial test.Back to article page